Clinical Trial Update: Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon [NA]

View source ↗

Summary

A clinical trial evaluating Diosmiplex (Vasculera) for primary and secondary Raynaud's phenomenon has completed. The study was sponsored by Primus Pharmaceutica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• Vasculera

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Raynaud's Disease | NA | Status: COMPLETED